Fernando Goldsztein is a Brazilian entrepreneur, philanthropist, and founder of the Medulloblastoma Initiative (MBI), a nonprofit organization dedicated to accelerating research and developing more effective treatments, with the ultimate goal of finding a cure for medulloblastoma, the most common malignant brain tumor in children.
Driven by his personal experience as the father of a child diagnosed with medulloblastoma, Fernando founded MBI in 2021, working alongside renowned pediatric neuro-oncologist Dr. Roger J. Packer. MBI has developed an innovative, collaborative research model that brings together leading scientists and institutions across the United States, Canada, and Germany to accelerate scientific discoveries and translate research into clinical progress.
Fernando is also a board member of the Children's National Foundation in Washington, D.C., and an advocate for innovation, collaboration, and greater investment in pediatric cancer research.
His work has been featured by MIT Sloan, The Washington Post, People, Fox News, and MSNBC/MS NOW, among other media outlets. He has participated in international forums, including the Clinton Global Initiative, and was named 2026 Advocacy Leader of the Year by the Washington Business Journal as part of its Innovators in Healthcare Awards.
| Fernando Goldsztein, MBA | Points |
|---|---|
| Academic | 0 |
| Author | 0 |
| Influencer | 0 |
| Speaker | 1 |
| Entrepreneur | 5 |
| Analyst | 0 |
| Total | 6 |
Points based upon Thinkers360 patented algorithm.
2026 Advocacy Leader of the Year – Washington Business Journal
Tags: Healthcare
Clinton Global Initiative 2026 – Health Working Session
Tags: Healthcare, Innovation
2026 Advocacy Leader of the Year – Washington Business JournalClinton Global Initiative 2026 – Health Working Session
